118 related articles for article (PubMed ID: 28069799)
1. IKBKE Is Required during KRAS-Induced Pancreatic Tumorigenesis.
Rajurkar M; Dang K; Fernandez-Barrena MG; Liu X; Fernandez-Zapico ME; Lewis BC; Mao J
Cancer Res; 2017 Jan; 77(2):320-329. PubMed ID: 28069799
[TBL] [Abstract][Full Text] [Related]
2. Targeting the IκB Kinase Enhancer and Its Feedback Circuit in Pancreatic Cancer.
Challa S; Husain K; Kim R; Coppola D; Batra SK; Cheng JQ; Malafa MP
Transl Oncol; 2020 Feb; 13(2):481-489. PubMed ID: 32004866
[TBL] [Abstract][Full Text] [Related]
3. Ectopic expression of DOCK8 regulates lysosome-mediated pancreatic tumor cell invasion.
Gutierrez-Ruiz OL; Johnson KM; Krueger EW; Nooren RE; Cruz-Reyes N; Heppelmann CJ; Hogenson TL; Fernandez-Zapico ME; McNiven MA; Razidlo GL
Cell Rep; 2023 Sep; 42(9):113042. PubMed ID: 37651233
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic KRASG12D Reprograms Lipid Metabolism by Upregulating SLC25A1 to Drive Pancreatic Tumorigenesis.
Zhang R; Peng X; Du JX; Boohaker R; Estevao IL; Grajeda BI; Cox MB; Almeida IC; Lu W
Cancer Res; 2023 Nov; 83(22):3739-3752. PubMed ID: 37695315
[TBL] [Abstract][Full Text] [Related]
5. Leveraging Mechanisms Governing Pancreatic Tumorigenesis To Reduce Pancreatic Cancer Mortality.
Donahue TR; Dawson DW
Trends Endocrinol Metab; 2016 Nov; 27(11):770-781. PubMed ID: 27461042
[TBL] [Abstract][Full Text] [Related]
6. SERPINB1 promotes Senecavirus A replication by degrading IKBKE and regulating the IFN pathway via autophagy.
Yan J; Gao Y; Bai J; Li J; Li M; Liu X; Jiang P
J Virol; 2023 Oct; 97(10):e0104523. PubMed ID: 37811994
[TBL] [Abstract][Full Text] [Related]
7. Back to the drawing board: Re-thinking the role of GLI1 in pancreatic carcinogenesis.
Hogenson TL; Lauth M; Pasca diMagliano M; Fernandez-Zapico ME
F1000Res; 2014; 3():238. PubMed ID: 25352983
[TBL] [Abstract][Full Text] [Related]
8. Emerging roles of the solute carrier family in pancreatic cancer.
Wu Z; Xu J; Liang C; Meng Q; Hua J; Wang W; Zhang B; Liu J; Yu X; Shi S
Clin Transl Med; 2021 Mar; 11(3):e356. PubMed ID: 33783998
[TBL] [Abstract][Full Text] [Related]
9. Retraction Note: IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer.
Guo J; Kim D; Gao J; Kurtyka C; Chen H; Yu C; Wu D; Mittal A; Beg AA; Chellappan SP; Haura EB; Cheng JQ
Oncogene; 2024 Apr; 43(16):1231. PubMed ID: 38443683
[No Abstract] [Full Text] [Related]
10. Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer.
Halbrook CJ; Lyssiotis CA
Cancer Cell; 2017 Jan; 31(1):5-19. PubMed ID: 28073003
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility.
Knudsen ES; Balaji U; Mannakee B; Vail P; Eslinger C; Moxom C; Mansour J; Witkiewicz AK
Gut; 2018 Mar; 67(3):508-520. PubMed ID: 28073890
[TBL] [Abstract][Full Text] [Related]
12. Crizotinib, a MET inhibitor, prevents peritoneal dissemination in pancreatic cancer.
Takiguchi S; Inoue K; Matsusue K; Furukawa M; Teramoto N; Iguchi H
Int J Oncol; 2017 Jul; 51(1):184-192. PubMed ID: 28498406
[TBL] [Abstract][Full Text] [Related]
13. Loss of KDM6A Activates Super-Enhancers to Induce Gender-Specific Squamous-like Pancreatic Cancer and Confers Sensitivity to BET Inhibitors.
Andricovich J; Perkail S; Kai Y; Casasanta N; Peng W; Tzatsos A
Cancer Cell; 2018 Mar; 33(3):512-526.e8. PubMed ID: 29533787
[TBL] [Abstract][Full Text] [Related]
14. Dual Inhibition of Hedgehog and c-Met Pathways for Pancreatic Cancer Treatment.
Rucki AA; Xiao Q; Muth S; Chen J; Che X; Kleponis J; Sharma R; Anders RA; Jaffee EM; Zheng L
Mol Cancer Ther; 2017 Nov; 16(11):2399-2409. PubMed ID: 28864680
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.
Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D
Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929
[TBL] [Abstract][Full Text] [Related]
16. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma.
;
Cancer Cell; 2017 Aug; 32(2):185-203.e13. PubMed ID: 28810144
[TBL] [Abstract][Full Text] [Related]
17. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer.
Kamerkar S; LeBleu VS; Sugimoto H; Yang S; Ruivo CF; Melo SA; Lee JJ; Kalluri R
Nature; 2017 Jun; 546(7659):498-503. PubMed ID: 28607485
[TBL] [Abstract][Full Text] [Related]
18. Long-term Risk of Pancreatic Malignancy in Patients With Branch Duct Intraductal Papillary Mucinous Neoplasm in a Referral Center.
Pergolini I; Sahora K; Ferrone CR; Morales-Oyarvide V; Wolpin BM; Mucci LA; Brugge WR; Mino-Kenudson M; Patino M; Sahani DV; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Gastroenterology; 2017 Nov; 153(5):1284-1294.e1. PubMed ID: 28739282
[TBL] [Abstract][Full Text] [Related]
19. Acinar cell plasticity and development of pancreatic ductal adenocarcinoma.
Storz P
Nat Rev Gastroenterol Hepatol; 2017 May; 14(5):296-304. PubMed ID: 28270694
[TBL] [Abstract][Full Text] [Related]
20. IKBKE enhances TMZ-chemoresistance through upregulation of MGMT expression in glioblastoma.
Guo G; Sun Y; Hong R; Xiong J; Lu Y; Liu Y; Lu J; Zhang Z; Guo C; Nan Y; Huang Q
Clin Transl Oncol; 2020 Aug; 22(8):1252-1262. PubMed ID: 31865606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
